Pegcetacoplan compared with supportive care for 26 weeks for participants with paroxysmal nocturnal hemoglobinuria: a plain language summary

In the PRINCE study, adults with paroxysmal nocturnal hemoglobinuria (PNH) who had not recently taken a C5 complement inhibitor medicine received pegcetacoplan or supportive care. Pegcetacoplan reduced hemolysis better than supportive care and was well tolerated.

Saved in:
Bibliographic Details
Published in:Future Rare Diseases Vol. 4; no. 1
Main Authors: Ming Wong, Raymond Siu, Navarro-Cabrera, Juan Ramon, Comia, Narcisa Sonia, Goh, Yeow Tee, Idrobo, Henry, Kongkabpan, Daolada, Gómez-Almaguer, David, Al-Adhami, Mohammed, Ajayi, Temitayo, Alvarenga, Paulo, Savage, Jessica, Deschatelets, Pascal, Francois, Cedric, Grossi, Federico, Dumagay, Teresita
Format: Journal Article
Language:English
Published: Future Medicine Ltd 31.12.2024
Subjects:
ISSN:2399-5262, 2399-5270, 2399-5270
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract In the PRINCE study, adults with paroxysmal nocturnal hemoglobinuria (PNH) who had not recently taken a C5 complement inhibitor medicine received pegcetacoplan or supportive care. Pegcetacoplan reduced hemolysis better than supportive care and was well tolerated.
AbstractList In the PRINCE study, adults with paroxysmal nocturnal hemoglobinuria (PNH) who had not recently taken a C5 complement inhibitor medicine received pegcetacoplan or supportive care. Pegcetacoplan reduced hemolysis better than supportive care and was well tolerated.
Author Goh, Yeow Tee
Dumagay, Teresita
Idrobo, Henry
Alvarenga, Paulo
Deschatelets, Pascal
Ajayi, Temitayo
Grossi, Federico
Kongkabpan, Daolada
Ming Wong, Raymond Siu
Comia, Narcisa Sonia
Savage, Jessica
Francois, Cedric
Navarro-Cabrera, Juan Ramon
Al-Adhami, Mohammed
Gómez-Almaguer, David
AuthorAffiliation 9Department of Cellular Therapeutics, Makati Medical Centre, Makati City, Philippines
5Department of Haematology, Julian Coronel Medical Center, Cali, Colombia
6Department of Medicine, Songklanagarind Hospital, Songkhla, Thailand
4Department of Haematology, Singapore General Hospital, Singapore
1Sir YK Pao Centre for Cancer & Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, NT, Hong Kong
7Department of Haematology, University Hospital Dr. José Eleuterio González, Monterrey, Mexico
3Research Center, Mary Mediatrix Medical Center, Lipa, Philippines
8Apellis Pharmaceuticals, Inc., Waltham, MA, USA
2Department of Hematology, Edgardo Rebagliati Hospital, Lima, Peru
AuthorAffiliation_xml – name: 1Sir YK Pao Centre for Cancer & Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, NT, Hong Kong
– name: 2Department of Hematology, Edgardo Rebagliati Hospital, Lima, Peru
– name: 9Department of Cellular Therapeutics, Makati Medical Centre, Makati City, Philippines
– name: 3Research Center, Mary Mediatrix Medical Center, Lipa, Philippines
– name: 5Department of Haematology, Julian Coronel Medical Center, Cali, Colombia
– name: 7Department of Haematology, University Hospital Dr. José Eleuterio González, Monterrey, Mexico
– name: 6Department of Medicine, Songklanagarind Hospital, Songkhla, Thailand
– name: 4Department of Haematology, Singapore General Hospital, Singapore
– name: 8Apellis Pharmaceuticals, Inc., Waltham, MA, USA
Author_xml – sequence: 1
  givenname: Raymond Siu
  surname: Ming Wong
  fullname: Ming Wong, Raymond Siu
– sequence: 2
  givenname: Juan Ramon
  surname: Navarro-Cabrera
  fullname: Navarro-Cabrera, Juan Ramon
– sequence: 3
  givenname: Narcisa Sonia
  surname: Comia
  fullname: Comia, Narcisa Sonia
– sequence: 4
  givenname: Yeow Tee
  surname: Goh
  fullname: Goh, Yeow Tee
– sequence: 5
  givenname: Henry
  surname: Idrobo
  fullname: Idrobo, Henry
– sequence: 6
  givenname: Daolada
  surname: Kongkabpan
  fullname: Kongkabpan, Daolada
– sequence: 7
  givenname: David
  surname: Gómez-Almaguer
  fullname: Gómez-Almaguer, David
– sequence: 8
  givenname: Mohammed
  surname: Al-Adhami
  fullname: Al-Adhami, Mohammed
– sequence: 9
  givenname: Temitayo
  surname: Ajayi
  fullname: Ajayi, Temitayo
– sequence: 10
  givenname: Paulo
  surname: Alvarenga
  fullname: Alvarenga, Paulo
– sequence: 11
  givenname: Jessica
  surname: Savage
  fullname: Savage, Jessica
– sequence: 12
  givenname: Pascal
  surname: Deschatelets
  fullname: Deschatelets, Pascal
– sequence: 13
  givenname: Cedric
  surname: Francois
  fullname: Francois, Cedric
– sequence: 14
  givenname: Federico
  surname: Grossi
  fullname: Grossi, Federico
– sequence: 15
  givenname: Teresita
  surname: Dumagay
  fullname: Dumagay, Teresita
BookMark eNp1kEtOwzAQhi1UJErpkr0vEHDsvMwOVbykSrCAdeQ449QisSM7ofQQ3IGzcDIcgtixmof-mX_mO0ULYw0gdB6TC0rj_FK5OqKEsogQkh2hJWWcRynNyeIvz-gJWnuvK5IkOctZkS_RxxM0EgYhbd8Kg6XteuGgxns97LAf-966Qb8BlqGLlXWYZl-fe4BX_1MF8aCl7oUZ_DwTOvb94DvRYmPlMDoTsh10tmltpc3otLjCAgc3bXCwbEbRQHDqOuEOZ-hYidbD-jeu0MvtzfPmPto-3j1srreRjHmeRYLzupICiKoqVhNJU6FIRtJCcZLIhKVxmgGhkou4ZoVktUgTUqgUhEokK4CtUDTvlc5670CVvdPTAWVMyglnGXCWE85ywhn0fNarMXwEXmowEsq56qAOCAz8M_sNEi6DPQ
ContentType Journal Article
Copyright 2023 Apellis Pharmaceuticals, Inc.
Copyright_xml – notice: 2023 Apellis Pharmaceuticals, Inc.
DBID FUMOA
AAYXX
CITATION
DOI 10.2217/frd-2023-0006
DatabaseName Future Medicine (Open Access)
CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EISSN 2399-5270
ExternalDocumentID 10_2217_frd_2023_0006
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
EBS
FUMOA
0YH
AAYXX
CITATION
M4Z
TDBHL
ID FETCH-LOGICAL-c1976-a99dbcae0fbb3d0c25af06058f904c435156e02c9a1d38c3da5408f5eaf4c38e3
ISSN 2399-5262
2399-5270
IngestDate Sat Nov 29 07:51:13 EST 2025
Fri May 10 00:16:07 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1976-a99dbcae0fbb3d0c25af06058f904c435156e02c9a1d38c3da5408f5eaf4c38e3
OpenAccessLink http://dx.doi.org/10.2217/frd-2023-0006
ParticipantIDs crossref_primary_10_2217_frd_2023_0006
futurescience_futuremedicine_10_2217_frd_2023_0006
PublicationCentury 2000
PublicationDate 2024-12-31
PublicationDateYYYYMMDD 2024-12-31
PublicationDate_xml – month: 12
  year: 2024
  text: 2024-12-31
  day: 31
PublicationDecade 2020
PublicationTitle Future Rare Diseases
PublicationYear 2024
Publisher Future Medicine Ltd
Publisher_xml – name: Future Medicine Ltd
SSID ssib044737387
ssib044772808
ssib047299869
Score 2.2790024
Snippet In the PRINCE study, adults with paroxysmal nocturnal hemoglobinuria (PNH) who had not recently taken a C5 complement inhibitor medicine received pegcetacoplan...
SourceID crossref
futurescience
SourceType Index Database
Publisher
SubjectTerms anemia
lay summary
paroxysmal nocturnal hemoglobinuria
pegcetacoplan
plain language summary
Title Pegcetacoplan compared with supportive care for 26 weeks for participants with paroxysmal nocturnal hemoglobinuria: a plain language summary
URI http://dx.doi.org/10.2217/frd-2023-0006
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2399-5270
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssib044737387
  issn: 2399-5262
  databaseCode: M~E
  dateStart: 20210101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAWR
  databaseName: Taylor & Francis Open Access
  customDbUrl:
  eissn: 2399-5270
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssib044772808
  issn: 2399-5262
  databaseCode: 0YH
  dateStart: 20210301
  isFulltext: true
  titleUrlDefault: https://www.tandfonline.com
  providerName: Taylor & Francis
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbhMxELZC4YCEEAgQpQX5QLlECxvvP7cqtHBpVJUglVPktb1oRbO7SrJpeuENeAeehTMPxYy962SjHMqByyq2ZO_PfLFnPDPfEPI6FNJjSg1Ac4N_kx9kgZOm0nWyQHoZZwr3RF1sIhqN4svL5LzX-9PmwiyvoqKIV6uk-q-ihj4QNqbO_oO47aTQAb9B6HAFscP1VoI_V9-EWsBCV13x7RjzeV2hvo3RQjrkC2MMWXg0ZEfH7rVS3zU5Q7_iTay1TX6DnnJ1M5-CPIsSnQ6FTqGclsgnkhc1vJbJmoZ75oU9BO23qXEbGvCpJjHpX-DtPxjvkFXrz_Dcog0SvuA3U0yu-ZzX9sSaL5Ez0hlyMORnJsq3Rh8Elkyy3pRyagKAR1gmac4xGii3m8_HUp8jfVXldX-s1OahB7PUiu3aiBm5YEObmiNv1Y6-ZnH3tzG8vWUwpnmmspl0sJI8ZtnvoObe2jJtICOYUDjBBIZPcDj68sM75C6LggTX2LMfJ-3q5vsRskhFG20sDaZLJrZPbkhgccZ3nQfqKE0PDNtMR0PS2tD4EXnYmDH02MDvMemp4gn52YEebaFHEUJ0DT2K0KMANMrC37807HRrE3ZmzBp21MKOdmH3nnKqQUdb0NEGdE_Jl9OT8fCT05T7cMQAlGKHJ4lMBVdulqaedAULeOai1z5LXF-AWj8IQuUykfCB9GLhSQ7WRpwFime-8GLlPSN7RVmo54T6kYCNKg14zHV5dQ5jQs5T1wukDIXYJ2_a7zmpDKvLZKco9wnrfO2JabVxL7sHvbjt7Afk_hrch2RvMavVS3JPLBf5fPZKo-cvb6eykg
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pegcetacoplan+compared+with+supportive+care+for+26%C2%A0weeks+for+participants+with+paroxysmal+nocturnal+hemoglobinuria%3A+a+plain+language+summary&rft.jtitle=Future+Rare+Diseases&rft.au=Ming+Wong%2C+Raymond+Siu&rft.au=Navarro-Cabrera%2C+Juan+Ramon&rft.au=Comia%2C+Narcisa+Sonia&rft.au=Goh%2C+Yeow+Tee&rft.date=2024-12-31&rft.issn=2399-5270&rft.eissn=2399-5270&rft.volume=4&rft.issue=1&rft_id=info:doi/10.2217%2Ffrd-2023-0006&rft.externalDBID=n%2Fa&rft.externalDocID=10_2217_frd_2023_0006
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2399-5262&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2399-5262&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2399-5262&client=summon